BALA CYNWYD, Pa., Sept. 29, 2014 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Impax Laboratories, Inc. (Impax" or the "Company") (IPXL) securities during the period between May 20, 2013 and July 28, 2014, inclusive (the "Class Period").

Click here to learn more http://brodsky-smith.com/825-ipxl-impax-laboratories-inc.html, or call: 877-534-2590. There is no cost or obligation to you.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants failure to adhere to proper quality control and manufacturing practices at its Taiwan production facility could adversely affect its ability to launch its new drug, RYTARY and that the quality control and manufacturing issues were imperiling its ability to produce, sell, and distribute generic drugs. According to the Complaint, following the Company's July 29, 2014 announcement that the FDA had completed an inspection of the Company's Taiwan facility that revealed deficiencies, the value of Impax shares declined significantly.

If you have suffered a loss from investment in Impax securities purchased on or after May 20, 2013 and would like to learn more about the litigation and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://brodsky-smith.com/825-ipxl-impax-laboratories-inc.html. You may also request more information by contacting Brodsky-Smith by telephone at (877)534-2590.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and case action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome. Brodsky & Smith, LLC may not have filed a complaint.

SOURCE Brodsky & Smith, LLC